Shinya Tamaki

Sapporo, 0620931, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Journal: Japanese journal of clinical oncology

Published: February 16, 2026

Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective Study.

Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective Study.

Journal: Journal of gastrointestinal cancer

Published: February 06, 2026

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

Journal: British journal of clinical pharmacology

Published: January 27, 2026

Association of probiotic use with nivolumab efficacy in gastric cancer patients on gastric acid suppressants.

Association of probiotic use with nivolumab efficacy in gastric cancer patients on gastric acid suppressants.

Journal: iScience

Published: January 21, 2026

A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).

A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).

Journal: Scientific reports

Published: July 31, 2024

Favorable Prognosis in Patients With Multiple Myeloma and Lenalidomide-Induced Skin Rash: A Multicenter Retrospective Study.

Favorable Prognosis in Patients With Multiple Myeloma and Lenalidomide-Induced Skin Rash: A Multicenter Retrospective Study.

Journal: European journal of haematology

Published: July 09, 2024

Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).

Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).

Journal: Cancer

Published: February 13, 2024

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.

Journal: Scientific reports

Published: June 22, 2023

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment.

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment.

Journal: Scientific reports

Published: March 22, 2023

Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.

Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.

Journal: European journal of clinical pharmacology

Published: May 20, 2022

Impact of pre-existing interstitial lung abnormal shadow on lung injury development and severity in patients of non-small cell lung cancer treated with osimertinib.

Impact of pre-existing interstitial lung abnormal shadow on lung injury development and severity in patients of non-small cell lung cancer treated with osimertinib.

Journal: Cancer medicine

Published: February 11, 2022

Safety Evaluation of Initial CT-P6 Administration for 30 min during the Switch from Reference Trastuzumab in Maintenance Infusion: A Multicenter Observational Study.

Safety Evaluation of Initial CT-P6 Administration for 30 min during the Switch from Reference Trastuzumab in Maintenance Infusion: A Multicenter Observational Study.

Journal: Biological & pharmaceutical bulletin

Published: April 01, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026